Other Therapies for Reducing Low-Density Lipoprotein Cholesterol: Medications in Development-Reference-Cited by-同舟云学术

Other Therapies for Reducing Low-Density Lipoprotein Cholesterol: Medications in Development

Published:2009-03 Issue:1 Volume:38 Page:99-119
ISSN:0889-8529
Container-title:Endocrinology and Metabolism Clinics of North America
language:en
Short-container-title:Endocrinology and Metabolism Clinics of North America

Author:

Stein Evan A.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference70 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators;Sacks;N Engl J Med,1996

3. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

4. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial;Heart Protection Study Collaborative Group;Lancet,2002

5. Reduction of LDL cholesterol by 25–60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor;Nawrocki;Arterioscler Thromb Vasc Biol,1995

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Therapeutic Approaches for Familial Hypercholesterolemia;Annual Review of Medicine;2018-01-29

2. Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management;Pharmacological Research;2017-06

3. Therapeutic Management of Familial Hypercholesterolemia: Current and Emerging Drug Therapies;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2015-12

4. Novel Lipid-Lowering Agents;Dyslipidemias;2015

5. The Role of Antisense Oligonucleotide Therapy in Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management Recommendations;Current Atherosclerosis Reports;2014-11-15